BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

467 related articles for article (PubMed ID: 24231806)

  • 1. mTOR inhibition alleviates mitochondrial disease in a mouse model of Leigh syndrome.
    Johnson SC; Yanos ME; Kayser EB; Quintana A; Sangesland M; Castanza A; Uhde L; Hui J; Wall VZ; Gagnidze A; Oh K; Wasko BM; Ramos FJ; Palmiter RD; Rabinovitch PS; Morgan PG; Sedensky MM; Kaeberlein M
    Science; 2013 Dec; 342(6165):1524-8. PubMed ID: 24231806
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Medicine. A common pathway for a rare disease?
    Vafai SB; Mootha VK
    Science; 2013 Dec; 342(6165):1453-4. PubMed ID: 24357304
    [No Abstract]   [Full Text] [Related]  

  • 3. Neurometabolic disease: Treating mitochondrial diseases with mTOR inhibitors--a potential treatment for Leigh syndrome?
    Geach T
    Nat Rev Neurol; 2014 Jan; 10(1):2. PubMed ID: 24296657
    [No Abstract]   [Full Text] [Related]  

  • 4. PKC downregulation upon rapamycin treatment attenuates mitochondrial disease.
    Martin-Perez M; Grillo AS; Ito TK; Valente AS; Han J; Entwisle SW; Huang HZ; Kim D; Yajima M; Kaeberlein M; Villén J
    Nat Metab; 2020 Dec; 2(12):1472-1481. PubMed ID: 33324011
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential effects of mTOR inhibition and dietary ketosis in a mouse model of subacute necrotizing encephalomyelopathy.
    Bornstein R; James K; Stokes J; Park KY; Kayser EB; Snell J; Bard A; Chen Y; Kalume F; Johnson SC
    Neurobiol Dis; 2022 Feb; 163():105594. PubMed ID: 34933094
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Acarbose suppresses symptoms of mitochondrial disease in a mouse model of Leigh syndrome.
    Bitto A; Grillo AS; Ito TK; Stanaway IB; Nguyen BMG; Ying K; Tung H; Smith K; Tran N; Velikanje G; Urfer SR; Snyder JM; Barton J; Sharma A; Kayser EB; Wang L; Smith DL; Thompson JW; DuBois L; DePaolo W; Kaeberlein M
    Nat Metab; 2023 Jun; 5(6):955-967. PubMed ID: 37365290
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Regional metabolic signatures in the Ndufs4(KO) mouse brain implicate defective glutamate/α-ketoglutarate metabolism in mitochondrial disease.
    Johnson SC; Kayser EB; Bornstein R; Stokes J; Bitto A; Park KY; Pan A; Sun G; Raftery D; Kaeberlein M; Sedensky MM; Morgan PG
    Mol Genet Metab; 2020 Jun; 130(2):118-132. PubMed ID: 32331968
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Iron status influences mitochondrial disease progression in Complex I-deficient mice.
    Kelly CJ; Couch RK; Ha VT; Bodart CM; Wu J; Huff S; Herrel NT; Kim HD; Zimmermann AO; Shattuck J; Pan YC; Kaeberlein M; Grillo AS
    Elife; 2023 Feb; 12():. PubMed ID: 36799301
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The NDUFS4 Knockout Mouse: A Dual Threat Model of Childhood Mitochondrial Disease and Normative Aging.
    Grillo AS; Bitto A; Kaeberlein M
    Methods Mol Biol; 2021; 2277():143-155. PubMed ID: 34080150
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rapamycin enhances survival in a Drosophila model of mitochondrial disease.
    Wang A; Mouser J; Pitt J; Promislow D; Kaeberlein M
    Oncotarget; 2016 Dec; 7(49):80131-80139. PubMed ID: 27741510
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Proteomic and metabolomic analyses of mitochondrial complex I-deficient mouse model generated by spontaneous B2 short interspersed nuclear element (SINE) insertion into NADH dehydrogenase (ubiquinone) Fe-S protein 4 (Ndufs4) gene.
    Leong DW; Komen JC; Hewitt CA; Arnaud E; McKenzie M; Phipson B; Bahlo M; Laskowski A; Kinkel SA; Davey GM; Heath WR; Voss AK; Zahedi RP; Pitt JJ; Chrast R; Sickmann A; Ryan MT; Smyth GK; Thorburn DR; Scott HS
    J Biol Chem; 2012 Jun; 287(24):20652-63. PubMed ID: 22535952
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ndufs4 knockout mouse models of Leigh syndrome: pathophysiology and intervention.
    van de Wal MAE; Adjobo-Hermans MJW; Keijer J; Schirris TJJ; Homberg JR; Wieckowski MR; Grefte S; van Schothorst EM; van Karnebeek C; Quintana A; Koopman WJH
    Brain; 2022 Mar; 145(1):45-63. PubMed ID: 34849584
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Targeting NAD
    Lee CF; Caudal A; Abell L; Nagana Gowda GA; Tian R
    Sci Rep; 2019 Feb; 9(1):3073. PubMed ID: 30816177
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Succination is Increased on Select Proteins in the Brainstem of the NADH dehydrogenase (ubiquinone) Fe-S protein 4 (Ndufs4) Knockout Mouse, a Model of Leigh Syndrome.
    Piroli GG; Manuel AM; Clapper AC; Walla MD; Baatz JE; Palmiter RD; Quintana A; Frizzell N
    Mol Cell Proteomics; 2016 Feb; 15(2):445-61. PubMed ID: 26450614
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of clofibrate and KH176 on life span and motor function in mitochondrial complex I-deficient mice.
    Frambach SJCM; van de Wal MAE; van den Broek PHH; Smeitink JAM; Russel FGM; de Haas R; Schirris TJJ
    Biochim Biophys Acta Mol Basis Dis; 2020 Jun; 1866(6):165727. PubMed ID: 32070771
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tetracyclines promote survival and fitness in mitochondrial disease models.
    Perry EA; Bennett CF; Luo C; Balsa E; Jedrychowski M; O'Malley KE; Latorre-Muro P; Ladley RP; Reda K; Wright PM; Gygi SP; Myers AG; Puigserver P
    Nat Metab; 2021 Jan; 3(1):33-42. PubMed ID: 33462515
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Translational Medicine. A target for pharmacological intervention in an untreatable human disease.
    Johnson SC
    Science; 2014 Dec; 346(6214):1192. PubMed ID: 25477449
    [No Abstract]   [Full Text] [Related]  

  • 18. Post onset, oral rapamycin treatment delays development of mitochondrial encephalopathy only at supramaximal doses.
    Felici R; Buonvicino D; Muzzi M; Cavone L; Guasti D; Lapucci A; Pratesi S; De Cesaris F; Luceri F; Chiarugi A
    Neuropharmacology; 2017 May; 117():74-84. PubMed ID: 28161373
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Structural insights into respiratory complex I deficiency and assembly from the mitochondrial disease-related ndufs4
    Yin Z; Agip AA; Bridges HR; Hirst J
    EMBO J; 2024 Jan; 43(2):225-249. PubMed ID: 38177503
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A constant and similar assembly defect of mitochondrial respiratory chain complex I allows rapid identification of NDUFS4 mutations in patients with Leigh syndrome.
    Assouline Z; Jambou M; Rio M; Bole-Feysot C; de Lonlay P; Barnerias C; Desguerre I; Bonnemains C; Guillermet C; Steffann J; Munnich A; Bonnefont JP; Rötig A; Lebre AS
    Biochim Biophys Acta; 2012 Jun; 1822(6):1062-9. PubMed ID: 22326555
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.